Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

The role of HOXB2 and HOXB3 in acute myeloid leukemia.

Lindblad, Oscar LU ; Chougule, Rohit A. LU ; Moharram, Sausan A. LU ; Kabir, Nuzhat N ; Sun, Jianmin LU ; Kazi, Julhash U. LU orcid and Rönnstrand, Lars LU orcid (2015) In Biochemical and Biophysical Research Communications 467(4). p.742-747
Abstract
Acute myeloid leukemia (AML) is a heterogeneous aggressive disease and the most common form of adult leukemia. Mutations in the type III receptor tyrosine kinase FLT3 are found in more than 30% of patients. Drugs against FLT3 have been developed for the treatment of AML, but they lack specificity, show poor response and lead to the development of a resistant phenotype upon treatment. Therefore, a deeper understanding of FLT3 signaling will facilitate identification of additional pharmacological targets in FLT3-driven AML. In this report, we identify HOXB2 and HOXB3 as novel regulators of oncogenic FLT3-ITD-driven AML. We show that HOXB2 and HOXB3 expression is upregulated in a group of AML patients carrying FLT3-ITD. Overexpression of... (More)
Acute myeloid leukemia (AML) is a heterogeneous aggressive disease and the most common form of adult leukemia. Mutations in the type III receptor tyrosine kinase FLT3 are found in more than 30% of patients. Drugs against FLT3 have been developed for the treatment of AML, but they lack specificity, show poor response and lead to the development of a resistant phenotype upon treatment. Therefore, a deeper understanding of FLT3 signaling will facilitate identification of additional pharmacological targets in FLT3-driven AML. In this report, we identify HOXB2 and HOXB3 as novel regulators of oncogenic FLT3-ITD-driven AML. We show that HOXB2 and HOXB3 expression is upregulated in a group of AML patients carrying FLT3-ITD. Overexpression of HOXB2 or HOXB3 in mouse pro-B cells resulted in decreased FLT3-ITD-dependent cell proliferation as well as decreased colony formation and increased apoptosis. Expression of HOXB2 or HOXB3 resulted in a significant decrease in FLT3-ITD-induced AKT, ERK, p38 and STAT5 phosphorylation. Our data suggest that HOXB2 and HOXB3 act as a tumor suppressors in FLT3-ITD driven AML. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Biochemical and Biophysical Research Communications
volume
467
issue
4
pages
742 - 747
publisher
Elsevier
external identifiers
  • pmid:26482852
  • wos:000365145300022
  • scopus:84946605856
  • pmid:26482852
ISSN
1090-2104
DOI
10.1016/j.bbrc.2015.10.071
language
English
LU publication?
yes
id
21bd247d-17a5-4cb7-854f-ca516ac48882 (old id 8148844)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26482852?dopt=Abstract
date added to LUP
2016-04-01 10:27:03
date last changed
2022-04-12 06:28:08
@article{21bd247d-17a5-4cb7-854f-ca516ac48882,
  abstract     = {{Acute myeloid leukemia (AML) is a heterogeneous aggressive disease and the most common form of adult leukemia. Mutations in the type III receptor tyrosine kinase FLT3 are found in more than 30% of patients. Drugs against FLT3 have been developed for the treatment of AML, but they lack specificity, show poor response and lead to the development of a resistant phenotype upon treatment. Therefore, a deeper understanding of FLT3 signaling will facilitate identification of additional pharmacological targets in FLT3-driven AML. In this report, we identify HOXB2 and HOXB3 as novel regulators of oncogenic FLT3-ITD-driven AML. We show that HOXB2 and HOXB3 expression is upregulated in a group of AML patients carrying FLT3-ITD. Overexpression of HOXB2 or HOXB3 in mouse pro-B cells resulted in decreased FLT3-ITD-dependent cell proliferation as well as decreased colony formation and increased apoptosis. Expression of HOXB2 or HOXB3 resulted in a significant decrease in FLT3-ITD-induced AKT, ERK, p38 and STAT5 phosphorylation. Our data suggest that HOXB2 and HOXB3 act as a tumor suppressors in FLT3-ITD driven AML.}},
  author       = {{Lindblad, Oscar and Chougule, Rohit A. and Moharram, Sausan A. and Kabir, Nuzhat N and Sun, Jianmin and Kazi, Julhash U. and Rönnstrand, Lars}},
  issn         = {{1090-2104}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{742--747}},
  publisher    = {{Elsevier}},
  series       = {{Biochemical and Biophysical Research Communications}},
  title        = {{The role of HOXB2 and HOXB3 in acute myeloid leukemia.}},
  url          = {{https://lup.lub.lu.se/search/files/7283575/1854133.pdf}},
  doi          = {{10.1016/j.bbrc.2015.10.071}},
  volume       = {{467}},
  year         = {{2015}},
}